Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-07-061663
Filing Date
2007-10-10
Accepted
2007-10-10 15:03:59
Documents
2
Period of Report
2007-10-12

Document Format Files

Seq Description Document Type Size
1 RS (INTERMUNE) - FORM 3 rrd173962.html 3  
1 RS (INTERMUNE) - FORM 3 rrd173962.xml 3 2647
2 POWER OF ATTORNEY rrd154140_174674.htm EX-24. 2248
  Complete submission text file 0001181431-07-061663.txt   6728
Mailing Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 415-466-2264
Steele Robin Joan (Reporting) CIK: 0001301008 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33730 | Film No.: 071165164

Mailing Address 222 THIRD AVENUE SUITE 2300 CAMBRIDGE MA 02142
Business Address 222 THIRD AVENUE SUITE 2300 CAMBRIDGE MA 02142 (617) 557-9020
Targanta Therapeutics Corp. (Issuer) CIK: 0001398161 (see all company filings)

EIN.: 203971077 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations